A significant discovery in cancer investigation is emerging with the use of mini-antibodies to re-engage damaged p53. This vital malignant inhibitor protein is frequently lost in several forms of cancer, resulting https://atozbookmarkc.com/story22161326/mini-antibodies-revive-tumor-suppressor-p53-a-new-approach-for-malignant-therapy